MyFinsight
Home
Blog
About
Contact
Download
Download image
Interest and other
income, net
$26,000K
Net loss
-$258,131K
Total interest and
other income
$26,000K
Product revenue, net
$172,042K
Other revenue
$19,547K
Loss from operations
-$278,131K
Total revenue
$191,589K
Equity method
investment loss
-$6,000K
Total operating
expenses
$469,720K
Selling, general and
administrative
$256,652K
Research and development
$200,518K
Cost of product
revenue
$12,550K
Back
Back
Income Statement
source: myfinsight.com
SpringWorks Therapeutics, Inc. (SWTX)
SpringWorks Therapeutics, Inc. (SWTX)